2022 annual financial data
Cytosorbents Corporation 2022 Operating margin
Cytosorbents Corporation 2022 operating margin with verified reported values.
Direct answer
Operating margin was -90.87%.
Operating income was -31,521,879 USD and net income was -32,812,582 USD.
Operating cash flow was -28,234,282 USD.
Get free Cytosorbents Corporation email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 34,688,809 USD
- Operating income
- -31,521,879 USD
- Net income
- -32,812,582 USD
- Operating cash flow
- -28,234,282 USD